The Center for Grassroots Oversight

This page can be viewed at http://www.historycommons.org/timeline.jsp?timeline=anthraxattacks&anthraxattacks_other=anthraxattacks_cipro___bayer


Follow Us!

We are planning some big changes! Please follow us to stay updated and be part of our community.

Twitter Facebook

2001 Anthrax Attacks

Cipro / Bayer

Project: 2001 Anthrax Attacks
Open-Content project managed by Paul, KJF, paxvector

add event | references

The Sunday Times reports that an inquiry has been launched into the behavior of Bayer, after revelations in a British trial regarding the anthrax antibiotic drug Cipro. The drug has been tested on hundreds despite the company having conducted studies which showed it reacted badly with other drugs, seriously impairing its ability to kill bacteria. These results are kept secret. Nearly half of those on whom the drug was tested at one test center develop a variety of potentially life-threatening infections, while data at other test centers is unknown. (Sunday Times (London) 5/14/2000)

The FDA endorses the use of Bayer’s Cipro drug to prevent inhalation anthrax. (Reuters 7/28/2000) An official recommendation like this is highly unusual for the FDA. A 1997 Pentagon study of anthrax in rhesus monkeys showed that several other drugs were as effective as Cipro. The reason given for only recommending Cipro is the government wants a weapon against anthrax should it come up against a strain resistant to drugs in the penicillin and tetracycline families of antibiotics. (Bumiller 10/21/2001) The pharmaceutical industry spent $177 million on lobbying in 1999 and 2000—more money than any other industry. The FDA has been accused of conflicts of interest with companies including Bayer. (Wayne and Petersen 11/4/2001)

On the evening after the 9/11 attacks, some White House personnel, including Vice President Dick Cheney’s staff, are given the anti-anthrax drug Cipro, and told to take it regularly. (Sobieraj 10/24/2001) An unnamed “high government official” also advises some reporters to take Cipro shortly after 9/11 (see Shortly After September 11, 2001). Judicial Watch will later sue the Bush administration to release documents showing who knew what and when, and why presidential staff were protected while senators, congresspeople, and others were not. (Associated Press 6/8/2002)

Richard Cohen.Richard Cohen. [Source: Washington Post]Washington Post journalist Richard Cohen will later write: “The [2001 anthrax] attacks were not entirely unexpected. I had been told soon after Sept. 11 to secure Cipro, the antidote to anthrax. The tip had come in a roundabout way from a high government official, and I immediately acted on it. I was carrying Cipro way before most people had ever heard of it.” (http://www.slate.com/id/2186766/ 3/18/2008) He will explain on a different occasion, “On a tip, I asked my doctor early on to prescribe Cipro for me, only to find out that, insider though I thought I was, nearly everyone had been asking him for the same thing.” (Cohen 7/22/2004) A number of White House officials begin taking Cipro the evening of September 11, 2001 (see Evening, September 11, 2001). Also, on September 26, well before any reports of real anthrax attacks, New York Times columnist Maureen Dowd will write, “Americans are now confronted with the specter of terrorists in crop dusters and hazardous-waste trucks spreading really terrifying, deadly toxins like plague, smallpox, blister agents, nerve gas and botulism. Women I know in New York and Washington… share information on which pharmacies still have Cipro, Zithromax and Doxycycline, all antibiotics that can be used for anthrax, the way they once traded tips on designer shoe bargains.” (Dowd 9/26/2001)

The Canadian government overrides Bayer’s patent for the anthrax antibiotic Cipro and orders a million tablets of a generic version from another company. The US government says it is not considering a similar move. Patent lawyers and politicians state that adjusting Bayer’s patent to allow other companies to produce Cipro is perfectly legal and necessary. (Harmon and Pear 10/19/2001) The New York Times notes that the White House seems “so avidly to be siding with the rights of drug companies to make profits rather than with consumers worried about their access to the antibiotic Cipro,” and points out huge recent contributions by Bayer to Republicans. (Bumiller 10/21/2001)

The Bayer Corporation, holders of the US patent on the anthrax antibiotic Cipro, agrees with the US to reduce the price of Cipro in the US from $1.83 to 95 cents. Analysts say the price reduction will reduce Bayer’s profit margin from 95% to 65%. This reduction applies only to sales to the US government, not sales to the public. (Wayne and Petersen 11/4/2001) Bayer has allowed no other companies to produce or import Cipro into the US. Other countries with less stringent patent laws sell Cipro for 1/30th the US price, and have offered to import large quantities into the US. (Bradsher 10/21/2001) Nevertheless, a class action suit by over one million Americans has been filed against Bayer and two other companies, alleging that Bayer has paid $200 million to two competitors to not make generic versions of Cipro. (Lieff Cabraser Heimann & Bernstein 10/25/2001) The profits from Cipro are considered a “lifesaver” for Bayer, which had been considering pulling out of pharmaceuticals altogether. (Kelso et al. 10/31/2001)

The New York Times reports that health officials and experts believe numerous other drugs are as effective as the antibiotic Cipro in combating anthrax. “Several generic antibiotics, including doxycycline, a kind of tetracycline, and various penicillins, are also effective against the disease,” and they all are in plentiful supply. (Abelson and Pollack 10/23/2001) A 1997 Pentagon study of anthrax in rhesus monkeys showed the other drugs to be equally effective. But Cipro remains the only drug officially recommended by the FDA (see July 27, 2000). (Bumiller 10/21/2001)


Creative Commons License Except where otherwise noted, the textual content of each timeline is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike